Активирующие мутации EGFR, ALK и ROS1 при НМРЛ – стандарт выбора лечебной тактики, перспективы
Активирующие мутации EGFR, ALK и ROS1 при НМРЛ – стандарт выбора лечебной тактики, перспективы
д.м.н. Д.Д. Сакаева (Уфа)
1 month ago 00:24:11 2.2K
3 months ago 01:33:21 43
3 months ago 01:31:06 28
3 months ago 01:27:49 36
3 months ago 01:46:52 44
3 months ago 01:30:41 6
3 months ago 01:12:38 10
3 months ago 01:09:20 9
3 months ago 01:46:32 16
3 months ago 01:34:21 41
3 months ago 01:37:37 46
3 months ago 01:08:23 9
3 months ago 01:04:59 5
3 months ago 01:53:38 50
3 months ago 00:14:52 1
3 months ago 01:52:24 4
3 months ago 00:15:06 8
4 months ago 01:28:53 50
5 months ago 00:29:15 4
5 months ago 00:13:51 5
5 months ago 00:20:52 1
5 months ago 00:14:39 1
5 months ago 00:15:40 1
5 months ago 00:25:06 2
